3rd World Conference on Access to Medical Products
19-21 November 2019
New Delhi, India
- Suman Rijal, Director of DNDi Regional Office – session on medical products for end game for HIV, TB, and malaria
- Michelle Childs, Head of Policy Advocacy – session on antimicrobial resistance
Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta analysis
by WWARN Methodology Study Group – includes Kiechel JR as co-author.
Malaria Journal, July 2019
Un Seul Monde – SDC Magazine [June 2019]
“Partnerships that save lives”
Klicken Sie hier, um den Artikel zu lesen / Cliquez ici pour lire l’article / Clicca qui per leggere l’articolo
Priorité Santé, RFI [24 May 2019]
“Les maladies tropicales négligées” – “Neglected tropical diseases”
Programme on neglected tropical diseases including an interview with Dr Bernard Pécoul, Executive Director at DNDi (from 14:48).
Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
by Guidi M, Mercier T, Aouri M, Decosterd LA, Csajka C, Ogutu B, Carn G, Kiechel JR.
Malaria Journal, April 2019
O Globo [30 July 2018]
“Malária, a febre das febres” – “Malaria, the fever of fevers”
O Globo [29 July 2018]
“Doenças da desigualdade: as dores que o Brasil não vê” – “Diseases of inequality: the pains that Brazil doesn’t see”
Healio [8 April 2018]
“International partnership invests $15.5 million to combat neglected tropical diseases, TB, malaria”
Geneva Health Forum
7th Edition: Precision Global Health in the Digital Age
10-12 April 2018
Geneva, Switzerland
Bernard Pécoul, Executive Director – plenary talk on emerging infectious diseases crisis
Digas Ngolo, Investigator Coordinator, DNDi Africa – parallel session on ehealth